Jason Kang, Ph.D.
CEO

Founded HELiXrUS, Inc., a digital healthcare company based on rich experience and knowledge in biotechnology research, startup companies, small and medium-sized businesses, and global companies for over 27 years

・ Commercial Leader, Illumina KOREA 2015-2021
・ Director of Sales, Thermo Fisher Scientific US         2008-2015
・ CTO, Macrogen KOREA 2003-2008
・ Director, Spectral Genomics, TX USA 2001-2003
・ National Institutes of Health, MD US (Post-doc)
・ Stanford Univ Medical Center, CA US (Post-Doc)
・ Thomas Jefferson Univ, PA US (PH.D) 1998
・ Carnegie Mellon Univ, PA US (BS) 1990
・ Expertise in management, product development,
      commercialization, clinical NGS, genomics, sales &
      marketing

・ Commercial Leader, Illumina KOREA 2015-2021
・ Director of Sales, Thermo Fisher Scientific US 2008-2015
・ CTO, Macrogen KOREA 2003-2008
・ Director, Spectral Genomics, TX USA 2001-2003
・ National Institutes of Health, MD US (Post-doc)
・ Stanford Univ Medical Center, CA US (Post-Doc)
・ Thomas Jefferson Univ, PA US (PH.D) 1998
・ Carnegie Mellon Univ, PA US (BS) 1990

・ Expertise in management, product development,
      commercialization, clinical NGS, genomics, sales & marketing

Nick Choe, M.S.
CEO

Over 20 years of experience as a leader of domestic bio-specialized channel management

・ LnCBio Inc, ㈜엘앤씨바이오 / CEO 2007-2020
      (Agilent Technologies / Twist Bioscience)
・ CoTech, GenoProt International,
      Sales and Marketing
・ GenomicBase, Technical Sales
・ Bio-Medical Science Co.,Ltd, Sales
・ DaeMyung Science, Sales and Marketing
・ Department of Developmental Toxicology,
      University of Michigan. USA – RA
・ University of Michigan. Ann Arbor, MI. USA ,
      M.S. Toxicology 2000
・ Kon-kuk University, Seoul, Korea, B.S. Biology 1997

・ LnCBio Inc, ㈜엘앤씨바이오 / CEO 2007-2020
      (Agilent Technologies / Twist Bioscience)
・ CoTech, GenoProt International,  Sales and Marketing
・ GenomicBase, Technical Sales
・ Bio-Medical Science Co.,Ltd, Sales
・ DaeMyung Science, Sales and Marketing
・ Department of Developmental Toxicology,
      University of Michigan. USA – RA
・ University of Michigan. Ann Arbor, MI. USA , M.S. Toxicology 2000
・ Kon-kuk University, Seoul, Korea, B.S. Biology 1997

Daniel Lee
Director
Leader in IT/artificial intelligence and professional management around the world over 25 years
・ CTO, PS Artificial Intelligence lab 2013 - Current
・ CEO, AppliedERP 2005-2013
・ Director, PeopleSoft 1998-2005
・ Researcher, IBM 1998
・ Gachon University, visiting professor 2016-2020
・ University of Southern California, Research Associate 1997-1998
・ Seoul National University, Research Fellow 1997
Jae H. Lee
Auditor
Extensive experiences in venture capital and investment management
over 25 years
・ Managing Partner, Platform Partners Asset Management
     2015 – Current
・ Managing Director / Analyst, Daiwa Securities 2001-2014
・ Regional Analyst, Dresdner Kleinwort Benson Securities 1999-2001
・ TMT Analyst, Smith Barney 1997-1998
・ Equity Analyst, Credit Lyonnais Securities Asia 1996-1997
・ Indiana University, IN USA (MBA Finance) 1995
・ Carnegie Mellon University, PA USA (BS) 1991
JungWoo Lee
DIRECTOR
・ Vice President, Co-Founder, Molecular Diagnostics Korea, Inc. 2007~2021
・ CEO, Co-Founder, Dongyang, Inc. 2004~2007
・ Sales, Bio-Medical Science, Inc 2001~2004
・ Korea University Agricultural Chemistry MS 2001
・ Korea University Agricultural Chemistry BS 1999

Sung Bo Shim
Director
Experienced channel business leader over 20 years
・ MDxK Inc., CEO 2007 ~ Current
・ Marketing & Sales Team Leader, BMS
・ Handok Pharma, IVD Division Leader
・ B.S. in Biological Sciences, Inha University
Daniel Lee
Director
Leader in IT/artificial intelligence and professional management around the world over 25 years
・ CTO, PS Artificial Intelligence lab 2013 - Current
・ CEO, AppliedERP 2005-2013
・ Director, PeopleSoft 1998-2005
・ Researcher, IBM 1998・ Gachon University, visiting professor 2016-2020
・ University of Southern California, Research Associate 1997-1998
・ Seoul National University, Research Fellow 1997
Jae H. Lee
Auditor
Extensive experiences in venture capital and investment managementover 25 years
・ Managing Partner, Platform Partners Asset Management      2015 – Current
・ Managing Director / Analyst, Daiwa Securities 2001-2014
・ Regional Analyst, Dresdner Kleinwort Benson Securities 1999-2001
・ TMT Analyst, Smith Barney 1997-1998
・ Equity Analyst, Credit Lyonnais Securities Asia 1996-1997
・ Indiana University, IN USA (MBA Finance) 1995
・ Carnegie Mellon University, PA USA (BS) 1991
JungWoo Lee
Director
・ Vice President, Co-Founder, Molecular Diagnostics Korea, Inc. 2007~2021
・ CEO, Co-Founder, Dongyang, Inc. 2004~2007
・ Sales, Bio-Medical Science, Inc 2001~2004
・ Korea University Agricultural Chemistry MS 2001
・ Korea University Agricultural Chemistry BS 1999
Sung Bo Shim
Director
Experienced channel business leader over 20 years
・ MDxK Inc., CEO 2007 ~ Current
・ Marketing & Sales Team Leader, BMS
・ Handok Pharma, IVD Division Leader
・ B.S. in Biological Sciences, Inha University